Antithrombotic effects of a synthetic inhibitor of activated factor X, JTV-803, in animals.
暂无分享,去创建一个
[1] Y. Ikeda,et al. Antithrombotic effect of SM-20302, a nonpeptide GPIIb/IIIa antagonist, in a photochemically induced thrombosis model in guinea pigs. , 1999, Thrombosis research.
[2] Y. Terada,et al. DX-9065a, an Orally Active Factor Xa Inhibitor, Does not Facilitate Haemorrhage Induced by Tail Transection or Gastric Ulcer at the Effective Doses in Rat Thrombosis Model , 1999, Thrombosis and Haemostasis.
[3] K. Mann,et al. Evaluation of the Initiation Phase of Blood Coagulation Using Ultrasensitive Assays for Serine Proteases* , 1997, The Journal of Biological Chemistry.
[4] C. Doutremépuich,et al. Importance of photo activation of rose bengal for platelet activation in experimental models of photochemically induced thrombosis. , 1996, Thrombosis research.
[5] E. Topol,et al. Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.
[6] J. Freedman,et al. Control Mechanisms in Thrombin Generation , 1996, Seminars in thrombosis and hemostasis.
[7] S. Kunitada,et al. Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor. , 1995, Thrombosis research.
[8] H. Ishihara,et al. DX-9065a, an Orally Active, Specific Inhibitor of Factor Xa, Inhibits Thrombosis without Affecting Bleeding Time in Rats , 1995, Thrombosis and Haemostasis.
[9] J. Lynch,et al. Primary Prevention of Coronary Arterial Thrombosis with the Factor Xa Inhibitor rTAP in a Canine Electrolytic Injury Model , 1995, Thrombosis and Haemostasis.
[10] M. Nakashima,et al. Vessel Wall Injury and Arterial Thrombosis Induced by a Photochemical Reaction , 1995, Thrombosis and Haemostasis.
[11] G. Vlasuk,et al. Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. , 1994, Biochemistry.
[12] C. Dunwiddie,et al. Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. , 1994, Circulation.
[13] B. Francis,et al. Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis. , 1993, Thrombosis research.
[14] P. Schoen,et al. Flow and the inhibition of prothrombinase by antithrombin III and heparin. , 1991, Blood.
[15] C. Dunwiddie,et al. Comparison of the In Vivo Anticoagulant Properties of Standard Heparin and the Highly Selective Factor Xa Inhibitors Antistasin and Tick Anticoagulant Peptide (TAP) in a Rabbit Model of Venous Thrombosis , 1991, Thrombosis and Haemostasis.
[16] C. Dunwiddie,et al. Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa. , 1991, Archives of biochemistry and biophysics.
[17] L. Bush,et al. In vivo models of arterial thrombosis and thrombolysis , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[18] R. Colman,et al. Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin. , 1990, Thrombosis research.
[19] H. Pelzer,et al. Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay , 1988, Thrombosis and Haemostasis.
[20] I. Palacios,et al. Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.
[21] R. Rosenberg,et al. Protection of factor Xa from neutralization by the heparin-antithrombin complex. , 1983, The Journal of clinical investigation.
[22] R. Tidwell,et al. Strategies for anticoagulation with synthetic protease inhibitors. Xa inhibitors versus thrombin inhibitors. , 1980, Thrombosis research.
[23] K. Mann,et al. The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. , 1979, The Journal of biological chemistry.
[24] K. Váradi,et al. Optimization of conditions for the catalytic effect of the factor IXa-factor VIII complex: probable role of the complex in the amplification of blood coagulation. , 1979, Thrombosis research.
[25] J. Miletich,et al. Properties of the factor Xa binding site on human platelets. , 1978, The Journal of biological chemistry.